Précisez une action ou une cryptomonnaie dans la barre de recherche pour obtenir un récapitulatif
Linical Co Ltd
2183Linical Co., Ltd. provides drug development services primarily in the areas of oncology and central nervous system to pharmaceutical companies worldwide. The company offers drug development consulting services, such as market analysis of products in development, regulatory affairs consultation support, and licensing support. It also provides clinical research and development, and contract medical affairs services, including front-end services comprising project management, monitoring, quality control, vendor management, auditing, and clinical research secretariats; and back-end services, which include data management, bio statistical analysis, medical writing, pharmacovigilance, and medical management. The company was incorporated in 2005 and is headquartered in Osaka, Japan. Address: Shin-Osaka Brick Building, Osaka, Japan, 532-0003
Analytics
Objectif de Cours de WallStreet
421 193.25 JPYRatio C/B
24.4295Rendement du dividende
4.2 %Année actuelle
L'année dernière
Trimestre en cours
Le dernier trimestre
Année actuelle
L'année dernière
Trimestre en cours
Le dernier trimestre
Chiffres clés 2183
Analyse des dividendes 2183
Croissance des dividendes sur 5 ans
27 %Croissance continue
1 annéeRatio de distribution Moyenne sur 5 ans
36 %Historique des dividendes 2183
Valorisation des titres 2183
financières 2183
Résultats | 2019 | Dynamique |